 also have an
impact on life expectancy. One-year survival after hospital admission for heart failure is 60%. One-year survival
after initiation of dialysis is 85% but decreases for those
with signiÔ¨Åcant comorbidities to 60%. The 3-year survival
after initiation of home oxygen therapy for COPD is 60%.
In the EVAR 2 trial, patients with severe coronary artery
disease, COPD, or poor renal